Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Sep;63(3):304–308. doi: 10.1136/jnnp.63.3.304

GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs

P Jarman 1, O Bandmann 1, C Marsden 1, N Wood 1
PMCID: PMC2169710  PMID: 9328244

Abstract

OBJECTIVES—to investigate the hypothesis that GTP cyclohydrolase I (GCH1) mutations are responsible for the phenotype of highly anticholinergic responsive dystonia in patients with apparent primary torsion dystonia.
METHODS—from 107 British patients with clinically diagnosed primary torsion dystonia, seven patients were identified with an excellent response to anticholinergic drugs. All six exons of the GCH1 gene were sequenced in these patients to identify mutations.
RESULTS—three novel GCH1 mutations were identified in two patients. One patient was a compound heterozygote with asymptomatic carrier parents. The clinical phenotype of patients with and without GCH1 mutations was similar.
CONCLUSIONS—these findings show that a proportion of patients with apparent primary torsion dystonia and a good response to anticholinergic drugs have GCH1 mutations and therefore have a variant of dopa responsive dystonia. The difficulty in distinguishing clinically between patients with and without mutations underscores the importance of considering the diagnosis of a levodopa responsive dystonia in all such patients.



Full Text

The Full Text of this article is available as a PDF (108.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akli S., Chelly J., Mezard C., Gandy S., Kahn A., Poenaru L. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. J Biol Chem. 1990 May 5;265(13):7324–7330. [PubMed] [Google Scholar]
  2. Bandmann O., Nygaard T. G., Surtees R., Marsden C. D., Wood N. W., Harding A. E. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet. 1996 Mar;5(3):403–406. doi: 10.1093/hmg/5.3.403. [DOI] [PubMed] [Google Scholar]
  3. Bennett D. A., Wilson R. S., Gilley D. W., Fox J. H. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):961–965. doi: 10.1136/jnnp.53.11.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CORNER B. D. Dystonia musculorum deformans in siblings; treated with artane (trihexyphenidyl). Proc R Soc Med. 1952 Jul;45(7):451–452. doi: 10.1177/003591575204500710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983 Oct;33(10):1255–1261. doi: 10.1212/wnl.33.10.1255. [DOI] [PubMed] [Google Scholar]
  6. Fletcher N. A., Harding A. E., Marsden C. D. A genetic study of idiopathic torsion dystonia in the United Kingdom. Brain. 1990 Apr;113(Pt 2):379–395. doi: 10.1093/brain/113.2.379. [DOI] [PubMed] [Google Scholar]
  7. Furukawa Y., Shimadzu M., Rajput A. H., Shimizu Y., Tagawa T., Mori H., Yokochi M., Narabayashi H., Hornykiewicz O., Mizuno Y. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Ann Neurol. 1996 May;39(5):609–617. doi: 10.1002/ana.410390510. [DOI] [PubMed] [Google Scholar]
  8. Gardella R., Belletti L., Zoppi N., Marini D., Barlati S., Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet. 1996 Aug;59(2):292–300. [PMC free article] [PubMed] [Google Scholar]
  9. Harwood G., Hierons R., Fletcher N. A., Marsden C. D. Lessons from a remarkable family with dopa-responsive dystonia. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):460–463. doi: 10.1136/jnnp.57.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirano M., Tamaru Y., Nagai Y., Ito H., Imai T., Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. Biochem Biophys Res Commun. 1995 Aug 15;213(2):645–651. doi: 10.1006/bbrc.1995.2180. [DOI] [PubMed] [Google Scholar]
  11. Ichinose H., Ohye T., Matsuda Y., Hori T., Blau N., Burlina A., Rouse B., Matalon R., Fujita K., Nagatsu T. Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem. 1995 Apr 28;270(17):10062–10071. doi: 10.1074/jbc.270.17.10062. [DOI] [PubMed] [Google Scholar]
  12. Ichinose H., Ohye T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S., Fujita K., Nagatsu T. GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett. 1995 Aug 18;196(1-2):5–8. doi: 10.1016/0304-3940(95)11820-m. [DOI] [PubMed] [Google Scholar]
  13. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994 Nov;8(3):236–242. doi: 10.1038/ng1194-236. [DOI] [PubMed] [Google Scholar]
  14. Kramer P. L., de Leon D., Ozelius L., Risch N., Bressman S. B., Brin M. F., Schuback D. E., Burke R. E., Kwiatkowski D. J., Shale H. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol. 1990 Feb;27(2):114–120. doi: 10.1002/ana.410270203. [DOI] [PubMed] [Google Scholar]
  15. MUCKLOW E. S., METZ H. T. REMARKABLE RESPONSE TO BENZHEXOL HYDRO-CHLORIDE (ARTANE) IN CHILDREN WITH AN UNUSUAL PROGRESSIVE STRIATAL SYNDROME: A REPORT ON 3 CASES. Dev Med Child Neurol. 1964 Dec;6:598–605. doi: 10.1111/j.1469-8749.1964.tb02799.x. [DOI] [PubMed] [Google Scholar]
  16. Nygaard T. G., Marsden C. D., Duvoisin R. C. Dopa-responsive dystonia. Adv Neurol. 1988;50:377–384. [PubMed] [Google Scholar]
  17. Nygaard T. G., Marsden C. D., Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology. 1991 Feb;41(2 ):174–181. doi: 10.1212/wnl.41.2_part_1.174. [DOI] [PubMed] [Google Scholar]
  18. Nygaard T. G., Wilhelmsen K. C., Risch N. J., Brown D. L., Trugman J. M., Gilliam T. C., Fahn S., Weeks D. E. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet. 1993 Dec;5(4):386–391. doi: 10.1038/ng1293-386. [DOI] [PubMed] [Google Scholar]
  19. OLSZEWSKI J. Subcortical arteriosclerotic encephalopathy. Review of the literature on the so-called Binswanger's disease and presentation of two cases. World Neurol. 1962 May;3:359–375. [PubMed] [Google Scholar]
  20. Ozelius L., Kramer P. L., Moskowitz C. B., Kwiatkowski D. J., Brin M. F., Bressman S. B., Schuback D. E., Falk C. T., Risch N., de Leon D. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron. 1989 May;2(5):1427–1434. doi: 10.1016/0896-6273(89)90188-8. [DOI] [PubMed] [Google Scholar]
  21. Segawa M., Hosaka A., Miyagawa F., Nomura Y., Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol. 1976;14:215–233. [PubMed] [Google Scholar]
  22. Stöckler S., Isbrandt D., Hanefeld F., Schmidt B., von Figura K. Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet. 1996 May;58(5):914–922. [PMC free article] [PubMed] [Google Scholar]
  23. Warner T. T., Fletcher N. A., Davis M. B., Ahmad F., Conway D., Feve A., Rondot P., Marsden C. D., Harding A. E. Linkage analysis in British and French families with idiopathic torsion dystonia. Brain. 1993 Jun;116(Pt 3):739–744. doi: 10.1093/brain/116.3.739. [DOI] [PubMed] [Google Scholar]
  24. Weil D., D'Alessio M., Ramirez F., Steinmann B., Wirtz M. K., Glanville R. W., Hollister D. W. Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J Biol Chem. 1989 Oct 5;264(28):16804–16809. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES